These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30595837)

  • 1. Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from
    Takamatsu Y; Fujita M; Ho GJ; Wada R; Sugama S; Takenouchi T; Waragai M; Masliah E; Hashimoto M
    Parkinsons Dis; 2018; 2018():5789424. PubMed ID: 30595837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy.
    Wei J; Ho G; Masliah E; Hashimoto M
    Prion; 2023 Dec; 17(1):29-34. PubMed ID: 36785484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible Role of the Polyglutamine Elongation in Evolution of Amyloid-Related Evolvability.
    Hashimoto M; Ho G; Takamatsu Y; Wada R; Sugama S; Takenouchi T; Masliah E; Waragai M
    J Huntingtons Dis; 2018; 7(4):297-307. PubMed ID: 30372687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenerational Interaction of Alzheimer's Disease with Schizophrenia through Amyloid Evolvability.
    Takamatsu Y; Ho G; Waragai M; Wada R; Sugama S; Takenouchi T; Masliah E; Hashimoto M
    J Alzheimers Dis; 2019; 68(2):473-481. PubMed ID: 30741673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease.
    Hashimoto M; Ho G; Takamatsu Y; Wada R; Sugama S; Takenouchi T; Waragai M; Masliah E
    J Parkinsons Dis; 2019; 9(4):793-802. PubMed ID: 31524179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.
    Hashimoto M; Ho G; Takamatsu Y; Wada R; Sugama S; Waragai M; Masliah E; Takenouchi T
    Prion; 2020 Dec; 14(1):1-8. PubMed ID: 32375593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates.
    Hashimoto M; Ho G; Takamatsu Y; Shimizu Y; Sugama S; Takenouchi T; Waragai M; Masliah E
    J Parkinsons Dis; 2018; 8(3):405-408. PubMed ID: 30010144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolvability of Amyloidogenic Proteins in Human Brain.
    Hashimoto M; Ho G; Sugama S; Takamatsu Y; Shimizu Y; Takenouchi T; Waragai M; Masliah E
    J Alzheimers Dis; 2018; 62(1):73-83. PubMed ID: 29439348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connecting Alzheimer's Disease With Diabetes Mellitus Through Amyloidogenic Evolvability.
    Ho G; Takamatsu Y; Wada R; Sugama S; Waragai M; Takenouchi T; Masliah E; Hashimoto M
    Front Aging Neurosci; 2020; 12():576192. PubMed ID: 33192467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease.
    Wei J; Takamatsu Y; Wada R; Fujita M; Ho G; Masliah E; Hashimoto M
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of
    Wei J; Ho G; Takamatsu Y; Masliah E; Hashimoto M
    Parkinsons Dis; 2021; 2021():6318067. PubMed ID: 34858569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
    Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.
    Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
    J Am Geriatr Soc; 2013 Oct; 61(10):1714-21. PubMed ID: 24117286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epidemiology of Nonmotor Symptoms in Parkinson's Disease (Cohort and Other Studies).
    Katunina E; Titova N
    Int Rev Neurobiol; 2017; 133():91-110. PubMed ID: 28802941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
    Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Nonmotor Features of Parkinson's Disease.
    Titova N; Qamar MA; Chaudhuri KR
    Int Rev Neurobiol; 2017; 132():33-54. PubMed ID: 28554413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.